Cellares is a pioneering biotechnology company revolutionizing cell therapy manufacturing through its role as the first Integrated Development and Manufacturing Organization (IDMO). By integrating advanced automation, robotics, and software, Cellares aims to accelerate access to life-saving cell therapies. Their flagship platform, the Cell Shuttle™, is a fully automated, modular system capable of producing up to 16 different cell therapy batches simultaneously within a closed, ISO 8 cleanroom environment. This innovation offers a tenfold increase in productivity, up to 50% cost reduction per batch, and a 75% decrease in process failure rates compared to traditional contract development and manufacturing organizations (CDMOs). With smart factories operational in South San Francisco and Bridgewater, NJ, and plans for expansion into Europe and Asia, Cellares is committed to making personalized cell therapies more accessible and affordable worldwide .